- Report
- July 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- May 2024
- 169 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- December 2023
- 250 Pages
Global
€4767EUR$4,995USD£3,994GBP
Induced Pluripotent Stem Cells (iPSCs) are a type of stem cell that can be generated from adult cells, such as skin or blood cells. These cells have the potential to differentiate into any type of cell in the body, making them a valuable tool for drug discovery and development. In the pharmaceutical industry, iPSCs are used to create disease models, test drug efficacy, and develop personalized treatments.
iPSCs are also used in regenerative medicine, where they can be used to replace damaged or diseased cells. This has the potential to revolutionize the treatment of many diseases, including cancer, diabetes, and neurological disorders.
The iPSCs production market is growing rapidly, driven by increasing demand for personalized medicine and regenerative therapies. Companies in this market include Cellular Dynamics International, Takara Bio, and ReproCELL. Show Less Read more